» Articles » PMID: 19748655

Human Subjects Are Protected from Mast Cell Tryptase Deficiency Despite Frequent Inheritance of Loss-of-function Mutations

Overview
Date 2009 Sep 15
PMID 19748655
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mast cell tryptases have proposed roles in allergic inflammation and host defense against infection. Tryptase gene loci TPSAB1 and TPSB2 are known to be polymorphic, but the nature and extent of diversity at these loci have not been fully explored.

Objective: We sought to compare functional and nonfunctional tryptase allele frequencies and establish haplotypes in human populations.

Methods: Tryptase allele frequencies were determined by means of direct sequencing in 270 individuals from HapMap populations of European, African, Chinese, and Japanese ancestry. Haplotypes were predicted, validated in parent-child trios, and compared between populations.

Results: We identify a new frame-shifted tryptase allele (betaIII(FS)) carried by 23% and 19% of individuals of European and African ancestry but 0% of Asian subjects. Homology models predict that betaIII(FS) is functionless. Our genotyping assay shows that allele and haplotype distributions in each population are unique. Strong linkage disequilibrium between TPSAB1 and TPSB2 (r(2)=0.83, D'=0.85) yields 2 major and 5 minor tryptase haplotypes.

Conclusions: Tryptase deficiency alleles (alpha and the newly discovered betaIII(FS)) are common, causing the number of inherited active genes to range from a minimum of 2 to a maximum of 4, with major differences between populations in the proportion of individuals inheriting 2 versus 4 active alleles. African and Asian populations are especially enriched in genes encoding functional and nonfunctional tryptases, respectively. Strong linkage of TPSAB1 and TPSB2 and pairing of deficiency alleles with functional alleles in observed haplotypes protect human subjects from "knockout" genomes and indeed from inheritance of fewer than 2 active alleles.

Citing Articles

Exploring a pico-well based scRNA-seq method (HIVE) for simplified processing of equine bronchoalveolar lavage cells.

Fegraeus K, Riihimaki M, Nordlund J, Akula S, Wernersson S, Raine A PLoS One. 2025; 20(1):e0317343.

PMID: 39854349 PMC: 11760581. DOI: 10.1371/journal.pone.0317343.


A targeted amplicon next-generation sequencing assay for tryptase genotyping to support personalized therapy in mast cell-related disorders.

Li O, Hackney J, Choy D, Chang D, Nersesian R, Staton T PLoS One. 2024; 19(2):e0291947.

PMID: 38335181 PMC: 10857577. DOI: 10.1371/journal.pone.0291947.


Clinically accessible amplitude-based multiplex ddPCR assay for tryptase genotyping.

Svetina M, Selb J, Lyons J, Korosec P, Rijavec M Sci Rep. 2024; 14(1):2416.

PMID: 38287122 PMC: 10825142. DOI: 10.1038/s41598-024-52983-8.


The Clinical Features of Hereditary Alpha-Tryptasemia—Implications for Interdisciplinary Practice.

von Bubnoff D, Koch D, Stocker H, Ludwig R, Wortmann F, von Bubnoff N Dtsch Arztebl Int. 2024; 121(8):258-264.

PMID: 38260947 PMC: 11381211. DOI: 10.3238/arztebl.m2023.0287.


Mast Cell Activation Syndrome Update-A Dermatological Perspective.

Mihele D, Nistor P, Bruma G, Mitran C, Mitran M, Condrat C J Pers Med. 2023; 13(7).

PMID: 37511729 PMC: 10381535. DOI: 10.3390/jpm13071116.


References
1.
Costanzo M, Yabut S, Almond Jr H, Andrade-Gordon P, Corcoran T, de Garavilla L . Potent, small-molecule inhibitors of human mast cell tryptase. Antiasthmatic action of a dipeptide-based transition-state analogue containing a benzothiazole ketone. J Med Chem. 2003; 46(18):3865-76. DOI: 10.1021/jm030050p. View

2.
Huang C, Li L, Krilis S, Chanasyk K, Tang Y, Li Z . Human tryptases alpha and beta/II are functionally distinct due, in part, to a single amino acid difference in one of the surface loops that forms the substrate-binding cleft. J Biol Chem. 1999; 274(28):19670-6. DOI: 10.1074/jbc.274.28.19670. View

3.
Pereira P, Bergner A, Macedo-Ribeiro S, Huber R, Matschiner G, Fritz H . Human beta-tryptase is a ring-like tetramer with active sites facing a central pore. Nature. 1998; 392(6673):306-11. DOI: 10.1038/32703. View

4.
Selwood T, Wang Z, McCaslin D, Schechter N . Diverse stability and catalytic properties of human tryptase alpha and beta isoforms are mediated by residue differences at the S1 pocket. Biochemistry. 2002; 41(10):3329-40. DOI: 10.1021/bi015662v. View

5.
Trivedi N, Raymond W, Caughey G . Chimerism, point mutation, and truncation dramatically transformed mast cell delta-tryptases during primate evolution. J Allergy Clin Immunol. 2008; 121(5):1262-8. DOI: 10.1016/j.jaci.2008.01.019. View